Result: Risk Minimisation Materials for medicines starting with the letter Z

Zeposia

Bristol-Myers Squibb Pharmaceuticals limited

Zeposia (ozanimod) Healthcare Professional Prescriber’s Checklist

This risk minimisation material is a condition of the marketing authorisation. This checklist includes information on the ozanimod treatment initiation criteria (including re-initiation); monitoring parameters prior to, during and after treatment with ozanimod and counselling points for patients and pregnancy prevention for women of childbearing potential.

For Healthcare Professionals

Zeposia (ozanimod) Patient/Caregiver Guide

This risk minimisation material is a condition of the marketing authorisation. This guide should be provided to patients, or caregivers of patients, receiving treatment with ozanimod as it provides important information including what patients need to be aware of before they start taking ozanimod, the signs and symptoms of important side effects they need to look out for during treatment and how to report side effects.

Zeposia (ozanimod) Pregnancy-specific Patient Reminder Card

This risk minimisation material is a condition of the marketing authorisation. This card should be provided to women of childbearing potential receiving treatment with ozanimod. It contains information on the potential risks if ozanimod is used during pregnancy, how to minimise these risks through pregnancy prevention and what the patient should do if they become pregnant while on treatment with ozanimod.

Zerlinda

Accord-UK Ltd

Zoledronic acid - patient alert card

This reminder card contains important safety information that you need to be aware of before and during treatment with zoledronic acid (4mg/100ml solution for infusion; 4mg/5ml concentrate for solution for infusion) injections for cancer-related conditions.

Zessly

Sandoz Limited

Zessly Patient Alert Card

Zessly Patient Alert Card

Ziagen

ViiV Healthcare UK Ltd

Abacavir Hypersensitivity Slide Deck for Healthcare Professionals

Abacavir Hypersensitivity Slide Deck for Healthcare Professionals

For Healthcare Professionals

Abacavir Hypersensitivity Website for Healthcare Professionals

Abacavir Hypersensitivity Website for Healthcare Professionals

For Healthcare Professionals

Zoledronic acid

Dr. Reddy's Laboratories (UK) Ltd

Zoledronic acid 4mg/100ml solution for infusion; 4mg/5ml concentrate for solution for infusion patient reminder card

This reminder card contains important safety information that you need to be aware of before and during treatment with zoledronic acid (4mg/100ml solution for infusion; 4mg/5ml concentrate for solution for infusion) injections for cancer-related conditions.

Zoledronic acid 5mg/100ml solution for infusion patient reminder card

The reminder card contains important information that you need to be aware of before and during treatment with zoledronic acid (5mg solution for infusion).

Ranbaxy (UK) Limited a Sun Pharmaceutical Company

Doctor's information guide

Doctor's information guide - Zoledronic acid 5 mg

For Healthcare Professionals

Patient information guide

Patient information guide - Zoledronic acid 5 mg

Zoledronic Acid 5 mg solution for infusion - ONJ

Zoledronic Acid 5 mg solution for infusion - ONJ - patient reminder card

Mylan

Patient Reminder Card for osteonecrosis of the jaw

Patient reminder card for osteonecrosis of the jaw before and during treatment with zoledronic acid (4mg/100ml solution for infusion; 4mg/5ml concentrate for solution for infusion) injections

Zometa

Novartis Pharmaceuticals UK Ltd

ZOMETA patient reminder card

Educational material for the adverse event of osteonecrosis of the jaw